Print this page    •   Back to Web version of article

Table of Contents

June 1998

EDITORIAL

Should the Treatment of HIV Infection Be Left to Specialists?

The increasing complexity of therapy -- and the danger that inadequate treatment can actually promote the development of drug-resistant viral strains -- argues in favor of this approach
PAUL A. VOLBERDING, M.D., EDITOR-IN-CHIEF



THERAPEUTIC ADVANCES

OI Update: Pneumocystis carinii Pneumonia

The incidence is down, the treatments are better, but the threat remains
JUDITH A. ABERG, M.D.



NEWSLINE

Newsline...Newsline...Newsline...

Delays in obtaining care pose risks to patients and community: Counseling is essential to ensure that newly diagnosed patients begin therapy promptly... Prophylaxis following sexual exposure to HIV: Treat within 72 hours, especially if risk of infection is high... CD4 count and viral load do predict progression in pediatric patients: Viral load above 100,000 copies/mL mandates a change in therapy... Reinfusion of autologous CD8 cells: Experimental technique seems to improve immunologic parameters...



PULL OUT AND SAVE

How Drug Resistance Develops

Schematic color diagrams that will help you explain to your patients what resistance is, how it arises, and what can be done to prevent it
MOLLY COOKE, M.D.


Back to the June 1998 HIV Newsline contents page.




This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art12561.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.